During the elevation of reverse cortisone oxo-reductase activity of HSD11B1, the excessive and chronically sustained cortisol might promote adipocyte differentiation and inhibit pre-adipocyte proliferation, hence causing metabolic syndrome and dyslipidemia [15,16,17]. Here, HSD11B1 is linked to metabolic syndrome.